Polaris Group (TPE:6550)
Taiwan · Delayed Price · Currency is TWD 9.92
+0.02 (0.20%)
Sep 16, 2026, 2:39 PM CST
Polaris Group Market Cap
Polaris Group has a market cap or net worth of 8.88 billion as of September 18, 2026. Its market cap has decreased by -69.88% in one year.
Market Cap
8.88B
Enterprise Value
9.89B
Revenue
67.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.92
ChartMarket Cap Chart
Since February 15, 2016, Polaris Group's market cap has decreased from 46.46B to 8.88B, a decrease of -80.89%. That is a compound annual growth rate of -14.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 8.88B | -62.96% |
| Dec 31, 2025 | 23.96B | -29.66% |
| Dec 31, 2024 | 34.06B | -39.39% |
| Dec 29, 2023 | 56.21B | -14.57% |
| Dec 30, 2022 | 65.79B | 24.20% |
| Dec 30, 2021 | 52.97B | 373.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TCM Biotech International | 10.50B |
| Tanvex BioPharma | 8.61B |
| TWi Biotechnology | 8.26B |
| PharmaEngine | 7.99B |
| Locus Cell | 7.92B |
| Acepodia | 7.69B |
| Adimmune | 7.50B |
| AnnJi Pharmaceutical | 7.09B |